A5066881486- Malaria Research and Control
- Global Maternal and Child Health
- Mosquito-borne diseases and control
- Parasites and Host Interactions
- Pregnancy and Medication Impact
- Travel-related health issues
- COVID-19 Impact on Reproduction
Eijkman Institute for Molecular Biology
2019
Plasmodium falciparum and vivax infections are important causes of adverse pregnancy outcomes in the Asia-Pacific region. We hypothesised that monthly intermittent preventive treatment (IPT) or screening (IST) with dihydroartemisinin-piperaquine is more effective reducing malaria than existing single (SST) strategy, which used to screen women for at first antenatal visit followed by passive case detection, management febrile cases.
Abstract Background The sensitivity of rapid diagnostic tests (RDTs) for malaria is inadequate detecting low-density, often asymptomatic infections, such as those that can occur when screening pregnant women malaria. performance the Alere™ Ultra-sensitive Malaria Ag Plasmodium falciparum RDT (uRDT) was assessed retrospectively in Indonesia. Methods uRDT and CareStart™ HRP2/pLDH VOM ( vivax, ovale malariae ) Combo (csRDT) were using 270 stored red blood cell pellets plasma samples from women....
Malaria is one of the oldest infectious disease that continues to affect annually more than 200 million people globally. Pregnant women are second most vulnerable group malaria, besides children. A pregnant woman with malaria risks detrimental harm herself and her child resulting in adverse pregnancy outcomes. These outcomes contribute maternal, neonatal infant morbidity mortality. It essential protect from improve public health burden endemic countries.